We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Type 2 diabetes
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Type 2 diabetes is a common disease in which a person’s blood glucose levels are too high. We know that what we eat affects our blood glucose levels, and that changing our diets and losing weight can both help to control type 2 diabetes. However, it is not clear what the best advice is to help people achieve this goal. We know that it is possible for some people to improve their blood glucose levels by following a low-carbohydrate diet (cutting out starchy and sugary foods), but it is not clear whether the benefits come from eating less carbohydrate itself, or from losing weight at the same time (from eating less overall). We want to help answer this question by comparing two sorts of low-carbohydrate diets – one designed to help people lose weight at the same time, and one where people stay at the same weight but improve their blood glucose levels by changing the food they eat. This will help us give better advice to people living with type 2 diabetes about what is the right diet for them, to help them achieve their health goals.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Pregnant, breastfeeding, or planning to become pregnant during the course of the study.2. Recent weight loss (> 2kg in last 4 weeks; self-reported).3. People who are already following a specific restricted diet.4. Are currently taking more than two prescribed medications for diabetes glycaemic control.5. People with HbA1c > = 87 mmol/mol.6. Are currently using insulin therapy, SGLT2 inhibitors (Gliflozins – eg empaglifozin, dapagliflozin, canagliflozin), or GLP-1 agonists (e.g. exenatide, lixisenatide, liraglutide, dulaglutide and semaglutide).7. Previous or current eating disorder (or any other psychological condition) that may affect the participant’s ability to adhere to study intervention/experimental diets. 8. Recent myocardial infarction or stroke (< 3 months).9. Renal failure (chronic kidney disease stage 4 or 5).10. Current active treatment for cancer (other than skin cancer treated with curative intent by local treatment only).11. Proliferative diabetic retinopathy, or maculopathy.12. GP feels inappropriate to take part in study (e.g. unable to attend study visits; end of life care, or would not benefit from weight loss or improved diabetes control).13. Most recent (non-fasting or fasting) triglyceride level > 5 mmol/l.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Sam
West
+44 1865 289120
sam.west@phc.ox.ac.uk
The study is sponsored by University of Oxford and funded by NIHR Oxford Biomedical Research Centre.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 58895
You can print or share the study information with your GP/healthcare provider or contact the research team directly.